Work

endTB-Q trial: a caveat on confounding by baseline drug resistance – Authors' reply

Year: 2026

Type: letter

Source: The Lancet Respiratory Medicine

DOI: 10.1016/s2213-2600(26)00152-9

Authors: Lorenzo Guglielmetti, Maelenn Gouillou, Praharshinie Rupasinghe, Carole D Mitnick

Institutions: Epicentre, Instituut voor Tropische Geneeskunde, Harvard University

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7161271543

Cites: 3

Cited by:

Related to: 10